Pineal parenchymal tumor of intermediate differentiation

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:251919D44.5
Who is this for?
Show terms as
16Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Pineal parenchymal tumor of intermediate differentiation (PPTID) is a rare brain tumor that arises from the pineal gland, a small endocrine organ located deep in the center of the brain. PPTID is classified by the World Health Organization as a grade II or III tumor, falling on a spectrum between the more benign pineocytoma and the highly aggressive pineoblastoma. These tumors originate from the specialized cells (pinealocytes) of the pineal parenchyma and primarily affect the central nervous system. Because of the pineal gland's location near the cerebral aqueduct, tumor growth frequently leads to obstructive hydrocephalus — a dangerous buildup of cerebrospinal fluid within the brain — which causes symptoms such as headaches, nausea, vomiting, visual disturbances (particularly Parinaud syndrome, characterized by difficulty looking upward), and altered consciousness. Other symptoms may include gait abnormalities, cognitive changes, and fatigue. PPTID can occur in both children and adults, though it is most commonly diagnosed in adults. The clinical behavior of PPTID is variable; some tumors behave in a relatively indolent fashion while others may be more locally aggressive or, rarely, disseminate through the cerebrospinal fluid pathways. Diagnosis typically involves magnetic resonance imaging (MRI) of the brain followed by histopathological examination of tumor tissue obtained through biopsy or surgical resection. Treatment generally involves maximal safe surgical resection when feasible, often followed by adjuvant radiation therapy. The role of chemotherapy remains less well defined and is sometimes considered for higher-grade or recurrent tumors. Management of hydrocephalus, through endoscopic third ventriculostomy or ventriculoperitoneal shunting, is often a critical component of initial treatment. Prognosis is intermediate between pineocytoma and pineoblastoma, with outcomes depending on the degree of differentiation, extent of resection, and individual tumor biology.

Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Pineal parenchymal tumor of intermediate differentiation.

View clinical trials →

No actively recruiting trials found for Pineal parenchymal tumor of intermediate differentiation at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Pineal parenchymal tumor of intermediate differentiation community →

Specialists

16 foundView all specialists →
GM
Giles W. Robinson, MD
MEMPHIS, TN
Specialist
PI on 4 active trials1 Pineal parenchymal tumor of intermediate differentiation publication
TY
Tetsuya Yamamoto
Specialist
1 Pineal parenchymal tumor of intermediate differentiation publication
KA
Kirit Arumalla
SHREVEPORT, LA
Specialist
1 Pineal parenchymal tumor of intermediate differentiation publication
RT
Reo Tanoshima
Specialist
1 Pineal parenchymal tumor of intermediate differentiation publication
NS
Navneet Singla
Specialist
1 Pineal parenchymal tumor of intermediate differentiation publication
YN
Yoshihiko Nakamura
Specialist
1 Pineal parenchymal tumor of intermediate differentiation publication
NS
Nishanth Sadashiva
Specialist
1 Pineal parenchymal tumor of intermediate differentiation publication
HD
Harsh Deora
Specialist
1 Pineal parenchymal tumor of intermediate differentiation publication
SR
Shilpa Rao
Specialist
1 Pineal parenchymal tumor of intermediate differentiation publication
JS
Jitender Saini
Specialist
1 Pineal parenchymal tumor of intermediate differentiation publication
DS
Dhaval Shukla
Specialist
1 Pineal parenchymal tumor of intermediate differentiation publication
VS
Vani Santosh
Specialist
1 Pineal parenchymal tumor of intermediate differentiation publication
HT
Hajime Takase
Specialist
1 Pineal parenchymal tumor of intermediate differentiation publication
TT
Takafumi Tanei
Specialist
1 Pineal parenchymal tumor of intermediate differentiation publication
YN
Yusuke Nishimura
Specialist
1 Pineal parenchymal tumor of intermediate differentiation publication
HK
Hiroyuki Kato
Specialist
1 Pineal parenchymal tumor of intermediate differentiation publication

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Pineal parenchymal tumor of intermediate differentiation.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Pineal parenchymal tumor of intermediate differentiationForum →

No community posts yet. Be the first to share your experience with Pineal parenchymal tumor of intermediate differentiation.

Start the conversation →

Latest news about Pineal parenchymal tumor of intermediate differentiation

No recent news articles for Pineal parenchymal tumor of intermediate differentiation.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Pineal parenchymal tumor of intermediate differentiation

What is Pineal parenchymal tumor of intermediate differentiation?

Pineal parenchymal tumor of intermediate differentiation (PPTID) is a rare brain tumor that arises from the pineal gland, a small endocrine organ located deep in the center of the brain. PPTID is classified by the World Health Organization as a grade II or III tumor, falling on a spectrum between the more benign pineocytoma and the highly aggressive pineoblastoma. These tumors originate from the specialized cells (pinealocytes) of the pineal parenchyma and primarily affect the central nervous system. Because of the pineal gland's location near the cerebral aqueduct, tumor growth frequently lea

How is Pineal parenchymal tumor of intermediate differentiation inherited?

Pineal parenchymal tumor of intermediate differentiation follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

Which specialists treat Pineal parenchymal tumor of intermediate differentiation?

16 specialists and care centers treating Pineal parenchymal tumor of intermediate differentiation are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.